Gotham Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-46,090
| Closed | -$298K | – | 1314 |
|
|
2023
Q2 | $298K | Sell |
46,090
-77,174
| -63% | -$499K | 0.01% | 1126 |
|
|
2023
Q1 | $929K | Buy |
123,264
+7,162
| +6% | +$54K | 0.02% | 770 |
|
|
2022
Q4 | $1.18M | Buy |
116,102
+37,464
| +48% | +$380K | 0.03% | 623 |
|
|
2022
Q3 | $778K | Buy |
+78,638
| New | +$778K | 0.02% | 736 |
|
|
2022
Q1 | – | Sell |
-28,415
| Closed | -$406K | – | 1114 |
|
|
2021
Q4 | $406K | Sell |
28,415
-44,652
| -61% | -$638K | 0.01% | 847 |
|
|
2021
Q3 | $1.46M | Buy |
73,067
+47,579
| +187% | +$953K | 0.06% | 382 |
|
|
2021
Q2 | $561K | Buy |
+25,488
| New | +$561K | 0.02% | 653 |
|